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Background: Amyloid Beta (1-42) is derived from amyloid precursor protein and plays a 
critical role in AD pathogenesis. The purpose of this study was to investigate the effect of 
6 weeks of voluntary wheel running on brain Amyloid beta (1-42) in the diabetic rats 
induced with alloxan.  
Materials and Methods: 28 male rats weight 185±1 were assigned randomly to 4 groups 
(N=7): normal control (C), training (T), control-diabetic (CD) and diabetic-training (DT). 
Diabetes was induced with injecting Alloxan (120 mg/kg dissolved in saline) 
intraperitoneal.  
Results: 6 weeks of voluntary wheel running decreased the cortex Aβ1-42 in T and DT 
groups. Aβ1-42 levels significantly decreased in the T and DT in compare with C and CD 
(p<0.001), respectively. Also Aβ1-42 levels significantly increased in the CD in compare 
with C (p<0.001). 
Conclusion: voluntary exercise had positive effects on decreasing of Aβ1-42 levels during 6 
weeks. Therefore it can be recommended as therapeutic strategy for diabetes. 
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         Introduction 
myloid beta protein (Aβ) is one of the main 
factors in Alzheimer's pathogenesis [1, 2]. 
Accumulation and production of Aβ, are known 
as mechanisms to stimulate Alzheimer's disease
 [3, 4]. Aβ 
is formed through proteolysis of successive amyloid 
precursor protein (APP)
 [5]. The most common form of 
Aβ, is Aβ1-40 which is naturally secreted from the cells 
and It seems to be physiologically active [6]. Other 
species of Aβ, is Aβ1-42, which is more prone to 
accumulate. During life, Aβ1-40 (90%) and Aβ1-42 
(10%) are naturally produced in the brains of healthy 
people [7].  
Accumulation of Aβ1-42 results in amyloid plaque 
formation, and begin the cascade of events associated 
with neuronal and neurological disorders, inflammatory 
response, increased phosphorylation of protein tau, nerve 
cell death, neurological transporters disorder and clinical 
dementia [8, 9]. This protein, has the ability to generate 
free radicals from hydrogen peroxide as well as 
stimulating inflammatory cells [10]. Aβ1-42 protein in 
astrocytes and in neurons can cause Reactive Oxygen 
Species (ROS) production through NADPH oxidase
 [11, 
12]. Diabetes is involved in the brain amyloid and tau 
metabolism [13].  
Changes in insulin and glucose homeostasis of 
peripheral organs of the body may influence brain insulin 
and its receptor function, and will increase amyloid beta 
oligomerization and tau hyperphosphorylation [13, 14]. 
Beta-amyloid changes have been reported in diabetic 
human and animal subjects, and some researches have 
been suggested an increase in amyloid of the brain in 
diabetic subjects. However, the amounts of Aβ in the 
brain of 702 cadavers have not been affected by excessive 
blood sugar
 [15]. Janson et al. have examined 92 human 
samples (male and female) and reported no increase in the 
brain Aβ of 28 diabetic patients
 [16]. Other study showed 
no changes in Aβ levels (Aβ1-40, Aβ1-42) of cortex and 
hippocampus of diabetic rats (induced by Streptozotocin 
injection) after 10 days of hypo-insulinemia
 [17]. Another 
study found no changes in the brain Aβ levels of diabetics 
who underwent high-fat diet [18]. However, the data 
indicate that insulin resistance caused by diet, increases 
Aβ41 and Aβ1-42 production in transegenic Alzheimer's 
mice
 [19].  
Li et al. showed that Aβ1-42 levels in the brain (frontal 
cortex) of type 1 and 2 diabetic rats have been increased 
significantly
 [20]. Jolivalt et al., indicated that 9 weeks of 
diabetes increased brain Aβ levels (whole brain except 
cerebellum) in animal subjects
  [21]. Another study 
showed that the levels of Aβ1-40 and Aβ1-42 increased in 
the brains of Alzheimer's female rats with high-fat diet 
and after 8, 12 and 16 weeks of age
 [22]. 
Running wheel will exert significant effects on rodent 
brain and behavior. Running wheel is a form of voluntary 
activity that is used in research on animal models and is a 
useful tool for neurobehavioral study in rodents. Unlike 
the harmful effects of forced treadmill running exercise 
on cognitive ability, voluntary training will not impose 
chronic stress associated with forced exercise. Several 
studies have reported contradictory results on the effects 
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of exercise and physical activity on levels of brain Aβ. In 
this regard, a study showed that 3-week running wheel 
reduced soluble Aβ fibrylar in rat cortex with Alzheimer's 
disease. However, differences between cortex soluble and 
insoluble Aβ42 of sedentary and active Alzheimer's rats 
have not been found to be statistically significant. 
Exercise also reduces Aβ fibrillary and improves behavior 
in rats with Alzheimer's disease. Aβ damage and 
cognitive decline in Alzheimer's disease can be improved 
through stimulation of the adaptive immune response
 
[23].  
Another study showed that 3-week voluntary running 
wheel does not change levels of insoluble amyloid beta 
(Aβ1-40, Aβ1-42) in the brain (hippocampus) of 
Alzheimer's rats [24]. In addition, 4 months of forced and 
voluntary running had no significant effects on levels of 
soluble Aβ (Aβ1-40, Aβ1-42) in the cortex and 
hippocampus of Alzheimer's rats [25]. However, followed 
by 5 months of voluntary running wheel significant 
reduction was observed in the extracellular Aβ plaques in 
the frontal cortex and hippocampus and cortex of 
Alzheimer's rats
  [26]. Running on a treadmill for 16 
weeks significantly reduced the brain Aβ1-42 protein 
levels in Alzheimer's and non Alzheimer's rats [27]. In 
another study, 5 weeks of treadmill running reduced 
levels of Aβ in Alzheimer's rats brain [28].  
Consequently, there is no consensus in the literature 
regarding the effects of exercise on amyloid beta. Some of 
them showed that the exercise reduces this protein but 
others have reported no change. Given these conflicting 
results and lack of information about the effect of 
voluntary exercise on amyloid beta levels in diabetic 
subjects, this study investigated the effects of 6 weeks 
voluntary training on the amyloid beta protein levels in 
cortex of diabetic rats. 
 
Materials and Methods 
 
In this study, 28 adult male Wistar rats (8 weeks of age 
and weight of 185±1 g) were randomly divided into 4 
groups (7 rats in each one): 1- the healthy control group 
(C): this group was not diabetic and did not exercise, 2- 
Training (T): this group was kept in cages equipped with 
wheels for 6 weeks, 3- Diabetic control (CD): the diabetic 
group was kept in cages without performing exercise for 6 
weeks, and 4- Diabetic Training (DT): the diabetic group 
was kept in cages equipped with running wheels for 6 
weeks. 
The maintenance and care of the experimental rats were 
in accordance with the guidelines of the Helsinki 
convention. Subjects were kept in standard condition 
(temperature of 22±2ºC with relative humidity of 50% 
and the 12:12 hours light/dark cycle) and had free access 
to food and water. After 16 hours of fasting, alloxan (120 
mg/kg) was dissolved in saline and injected to rats 
intraperitoneally. Five days after alloxan injection, their 
blood glucose levels were measured by sampling blood 
from their tail
 [29, 30]. Those with higher blood glucose 
concentrations from 250 mg/dl were identified as diabetic
 
[29].  
Training groups (2 groups, total of 14 rats) were kept 
individually in cages equipped with wheels (manufactured 
by School of Physical Education, Mazandaran University) 
and had free access to the wheels. This machine is 
equipped with counter that shows the mileage during the 
day. Mileage provided by any of the subjects was 
recorded at an exact time each morning. Subjects were 
anesthetized by intraperitoneal injection of ketamine (50 
mg/kg) and xylazine (6 mg/kg). To collect samples of 
cortex, the subjects were decapitated by scissors, the skull 
has been split using surgical scalpel and the brain was 
removed. Normal cortex of the brain was isolated by a 
surgical scalpel. Brain tissue was frozen by liquid 
nitrogen at 80ºC. The homogenized brain tissue was 
centrifuged at the speed of 10,000 rpm for 5 minutes
 [25].  
The supernatant was harvested and frozen by liquid 
nitrogen and were stored at 80ºC for subsequent 
measurements. Cortex levels of Aβ1-42 were measured 
with ELISA method according to manufacturer's 
instructions (Wuhan, China). Coefficient of variation 
(CV) and sensitivity of this method was estimated to be 
6.3% and 0.24 pg/ml, respectively. After collecting data, 
and to compare variables of four groups, the 
Kolmogorov-Smirnov test was used for examining 
normality of the data and One-way ANOVA and LSD 
post hoc tests to examine differences between Aβ1-42 of 
each group. All calculations were performed using SPSS-
19 statistical software, and significance domain was 
determined to be p≤0.05.  
 
Results 
 
Table 1 shows Weight values and cortical Aβ1-42 levels 
related to separate groups. The distance run by diabetic 
subjects was less than healthy subjects. The 6-week 
voluntary running exercise in healthy mice, decreased 
cortical Aβ1-42 levels significantly in group T (p<0.001). 
Also, the amount of cortical Aβ1-42 levels of DT group 
have been decreased compared to CD group (p<0.001). 
Cortical Aβ1-42 levels of CD group significantly 
increased compared to group C (p<0.001). 
However, cortical Aβ1-42 levels were not significantly 
different from T group compared with DT (p=0.411). The 
data associated with cortical Aβ1-42 levels, weight and 
distance (m) in each group are presented in figure 1 and 
table 1, respectively. 
Table 1. Values of cortical Aβ1-42 levels, weight and running distance 
in research groups 
Control 
(Mean±SD) 
Trining 
(Mean±SD) 
Control 
diabetes 
(Mean±SD) 
Diabetes 
training 
(Mean±SD) 
variable 
0.98±0.053  0.51±0.049  1.32±0.30  0.451±0.053   Aβ1-42 
348.29±6.65  326.14±3.28  231±5.59  233.71±24.93  Weight
-  3244±385.57  -  650.95±98.25  Running 
distance (m)
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Figure 1. Aβ1-42 levels of subjects’ brain cortex (**) Significant 
difference with control group (p<0.05); (++) significant difference with 
control group - diabetes (p<0.05); (##) significant difference with 
control group (p<0.05). 
 
Discussion 
 
In this study, weight and distance values in diabetic 
subjects were lower than in healthy subjects indicating the 
negative impact of diabetes on body weight and distance 
in the diabetic subjects. Cortical Aβ1-42 levels in CD 
group showed a significant increase. The injection of 
alloxan induced diabetes in CD and DT groups. Diabetes 
induction increased cortical Aβ1-42 levels. There were no 
significant differences in levels of Aβ1-42 in T and DT 
groups. Accumulation of amyloid beta has damaging 
effects on brain [31]. Accumulation of this protein as 
plaques in the brain is one of the main factors in 
Alzheimer's disease. Aβ accumulation in brain of diabetic 
rats has been associated with nerve inflammation and 
neuronal damage
 [20].  
Several possible mechanisms are identified for the 
relationship between diabetes and Aβ. For example, 
insulin deficiency is the primary event that leads to 
decrease in insulin signaling cascade in brain and 
behavioral disorders caused by diabetes. Deficiency in 
insulin signaling is associated with diabetes mellitus and 
may be the result of insulin deficiency (Type 1) or insulin 
resistance (Type 2). Reduced insulin signaling is related 
to increase in levels of Aβ protein. In other words, the 
protein levels of Aβ increases significantly in the brain of 
diabetic rats. Insulin degradation enzyme (IDE) can 
breakdown Aβ [16, 32]. Insulin deficiency and reduced 
signaling may contribute to reduced IDE expression and 
increased Aβ protein levels [21, 33]. The findings of the 
present study is consistent with other studies that reported 
increase in levels of Aβ1-42 induced by diabetes. The 
present study showed that 6 weeks of voluntary exercise 
reduced Aβ1-42 levels in healthy and diabetic exercise 
groups. Adlard et al. showed that 5 months of voluntary 
wheel running leads to a significant decrease in 
extracellular Aβ plaques in the frontal cortex (38%) and 
cortex located in the hippocampus (53%) and 
hippocampus (40%). They stated that voluntary exercise 
may mediate the amyloid precursor protein metabolism 
and Aβ cascade resulting decrease in the production of Aβ
 
[26]. Another possible mechanism in relation to exercise 
and Aβ levels is that up-regulation of Proteasome activity 
induced from exercise
  [34] can mediate proteolytic 
fragments degradation of amyloid precursor protein 
(which plays an important role in the production of Aβ) 
[35]. Cho et al. showed that 16 weeks of treadmill running 
decreased the Aβ1-42 levels in 13-months-old 
Alzheimer's rats. The results of their study showed that 
physical activity, possibly through the regulation of 
amyloid precursor protein or increasing amounts of 
degradation and scavenging Aβ plaques can reduce brain 
Aβ [36]. 
What is noteworthy in this study is that exercise could 
decrease Aβ1-42 protein levels of brain in diabetic 
subjects which indicates that voluntary exercise has 
positive effects in reducing the consequences of diabetes. 
The findings of this study showed that voluntary exercise 
can reduce Aβ load in an animal model of diabetes. While 
pharmacological interventions are seeking to reduce Aβ to 
block cascade of brain diseases especially Alzheimer's 
disease, the findings of the present study showed that 
voluntary exercise is a simple behavioral strategy that can 
induce resistance against the development of diabetic 
neuropathology in brain. According to this study it seems 
that voluntary exercise can reduce the accumulation of 
amyloid-induced diabetes in animal subjects, and hence 
can be effective as a nonpharmacological therapy. 
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